Geometry and subsidence history of the Dead Sea basin : a case for fluid-induced mid-crustal shear zone?

This paper is not subject to U.S. copyright. The definitive version was published in Journal of Geophysical Research 117 (2012): B01406, doi:10.1029/2011JB008711.Pull-apart basins are narrow zones of crustal extension bounded by strike-slip faults that can serve as analogs to the early stages of crustal rifting. We use seismic tomography, 2-D ray tracing, gravity modeling, and subsidence analysis to study crustal extension of the Dead Sea basin (DSB), a large and long-lived pull-apart basin along the Dead Sea transform (DST). The basin gradually shallows southward for 50 km from the only significant transverse normal fault. Stratigraphic relationships there indicate basin elongation with time. The basin is deepest (8–8.5 km) and widest (~15 km) under the Lisan about 40 km north of the transverse fault. Farther north, basin depth is ambiguous, but is 3 km deep immediately north of the lake. The underlying pre-basin sedimentary layer thickens gradually from 2 to 3 km under the southern edge of the DSB to 3–4 km under the northern end of the lake and 5–6 km farther north. Crystalline basement is ~11 km deep under the deepest part of the basin. The upper crust under the basin has lower P wave velocity than in the surrounding regions, which is interpreted to reflect elevated pore fluids there. Within data resolution, the lower crust below ~18 km and the Moho are not affected by basin development. The subsidence rate was several hundreds of m/m.y. since the development of the DST ~17 Ma, similar to other basins along the DST, but subsidence rate has accelerated by an order of magnitude during the Pleistocene, which allowed the accumulation of 4 km of sediment. We propose that the rapid subsidence and perhaps elongation of the DSB are due to the development of inter-connected mid-crustal ductile shear zones caused by alteration of feldspar to muscovite in the presence of pore fluids. This alteration resulted in a significant strength decrease and viscous creep. We propose a similar cause to the enigmatic rapid subsidence of the North Sea at the onset the North Atlantic mantle plume. Thus, we propose that aqueous fluid flux into a slowly extending continental crust can cause rapid basin subsidence that may be erroneously interpreted as an increased rate of tectonic activity.Fieldwork was funded by U.S. AID Middle Eastern Regional Cooperation Program grant M21–012, with in-kind contributions by Al-Balqa’ Applied University (Jordan), the Geophysical Institute of Israel, and the U.S. Geological Survey

Development and Validation of a Symptom-Based Activity Index for Adults With Eosinophilic Esophagitis

Standardized instruments are needed to assess the activity of eosinophilic esophagitis (EoE), to provide endpoints for clinical trials and observational studies. We aimed to develop and validate a patient-reported outcome (PRO) instrument and score, based on items that could account for variations in patients’ assessments of disease severity. We also evaluated relationships between patients’ assessment of disease severity and EoE-associated endoscopic, histologic, and laboratory findings

Phantosmia, Parosmia, and Dysgeusia Are Prolonged and Late-Onset Symptoms of COVID-19

Deficiencies in smell and taste are common symptoms of COVID-19. Quantitative losses are well surveyed. This study focuses on qualitative changes such as phantosmia (hallucination of smell), parosmia (alteration of smell), and dysgeusia (alteration of taste) and possible connections with the adaptive immune system. Subjective experience of deficiency in taste and smell was assessed by two different questionnaires after a median of 100 and 244 days after first positive RT-PCR test. SARS-CoV-2-specific antibody levels were measured with the iFlash-SARS-CoV-2 assay. After 100 days a psychophysical screening test for olfactory and gustatory dysfunction was administered. 30 of 44 (68.2%) participants reported a chemosensory dysfunction (14 quantitative, 6 qualitative, 10 quantitative, and qualitative) during COVID-19, eleven (25.0%) participants (1 quantitative, 7 qualitative, 3 quantitative, and quantity) after 100 days, and 14 (31.8%) participants (1 quantitative, 10 qualitative, 3 quantitative and qualitative) after 244 days. Four (9.1%) participants, who were symptom-free after 100 days reported now recently arisen qualitative changes. Serological and T-cell analysis showed no correlation with impairment of taste and smell. In conclusion, qualitative changes can persist for several months and occur as late-onset symptoms months after full recovery from COVID-19-induced quantitative losses in taste and smell

CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients.

BackgroundCOVID-19 has so far affected more than 250 million individuals worldwide, causing more than 5 million deaths. Several risk factors for severe disease have been identified, most of which coincide with advanced age. In younger individuals, severe COVID-19 often occurs in the absence of obvious comorbidities. Guided by the finding of cytomegalovirus (CMV)-specific T cells with some cross-reactivity to SARS-CoV-2 in a COVID-19 intensive care unit (ICU) patient, we decided to investigate whether CMV seropositivity is associated with severe or critical COVID-19. Herpes simplex virus (HSV) serostatus was investigated as control.MethodsNational German COVID-19 bio-sample and data banks were used to retrospectively analyze the CMV and HSV serostatus of patients who experienced mild (n = 101), moderate (n = 130) or severe to critical (n = 80) disease by IgG serology. We then investigated the relationship between disease severity and herpesvirus serostatus via statistical models.ResultsNon-geriatric patients (ConclusionsWe identified 'CMV-seropositivity' as a potential novel risk factor for severe COVID-19 in non-geriatric individuals in the studied cohorts. More mechanistic analyses as well as confirmation of similar findings in cohorts representing the currently most relevant SARS-CoV-2 variants should be performed shortly

Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis.

BACKGROUND & AIMS: It is not clear whether symptoms alone can be used to estimate the biologic activity of eosinophilic esophagitis (EoE). We aimed to evaluate whether symptoms can be used to identify patients with endoscopic and histologic features of remission. METHODS: Between April 2011 and June 2014, we performed a prospective, observational study and recruited 269 consecutive adults with EoE (67% male; median age, 39 years old) in Switzerland and the United States. Patients first completed the validated symptom-based EoE activity index patient-reported outcome instrument and then underwent esophagogastroduodenoscopy with esophageal biopsy collection. Endoscopic and histologic findings were evaluated with a validated grading system and standardized instrument, respectively. Clinical remission was defined as symptom score <20 (range, 0-100); histologic remission was defined as a peak count of <20 eosinophils/mm(2) in a high-power field (corresponds to approximately <5 eosinophils/median high-power field); and endoscopic remission as absence of white exudates, moderate or severe rings, strictures, or combination of furrows and edema. We used receiver operating characteristic analysis to determine the best symptom score cutoff values for detection of remission. RESULTS: Of the study subjects, 111 were in clinical remission (41.3%), 79 were in endoscopic remission (29.7%), and 75 were in histologic remission (27.9%). When the symptom score was used as a continuous variable, patients in endoscopic, histologic, and combined (endoscopic and histologic remission) remission were detected with area under the curve values of 0.67, 0.60, and 0.67, respectively. A symptom score of 20 identified patients in endoscopic remission with 65.1% accuracy and histologic remission with 62.1% accuracy; a symptom score of 15 identified patients with both types of remission with 67.7% accuracy. CONCLUSIONS: In patients with EoE, endoscopic or histologic remission can be identified with only modest accuracy based on symptoms alone. At any given time, physicians cannot rely on lack of symptoms to make assumptions about lack of biologic disease activity in adults with EoE. ClinicalTrials.gov, Number: NCT00939263